Latest News & Features
Europe
The licensing company’s CEO and GC accept that ‘tactical retreats and tactical gains’ are baked into the high-profile portfolio’s future, finds Marisa Woutersen. 27 February 2025
Europe
Concerns over misuse, side effects and counterfeits are tightening controls on the blockbuster treatments, says Iona Silverman of Freeths. 27 February 2025
Americas
Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice | New partner brings experience in biotechnology, life sciences, technology, artificial intelligence and sustainable energy. 27 February 2025
Europe
The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function claims, increasing the risk for infringers even if they modify products. Marisa Woutersen unpacks the debate over the UPC’s flexible approach to added matter and the urgency criteria. 25 February 2025
Biotechnology
Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing technology found invalid | Natera also faces separate trade secrets claims from Guardant Health over cancer blood tests. 25 February 2025
Americas
British pharma giant says that a Federal Circuit decision could stifle competition by lowering the bar for proving patent infringement | Earlier ruling ‘nullifies a statutory mechanism for expediting access to generic drugs and breaks sharply with precedent on inducement’ says UK pharma company. 20 February 2025
Americas
Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments. 20 February 2025
Americas
Patent Trial and Appeal Board rules all challenged claims were unpatentable | Decision follows Federal Circuit review that revived Apple’s challenge. 18 February 2025
Careers
David Por joins the firm’s Paris team as partner | New hire brings two decades of experience, including in healthcare and life sciences. 18 February 2025
Americas
The former USPTO director has filed her first amicus brief since rejoining private practice, arguing that instructions issued in a Texas court are “legally incorrect”. She tells Sarah Speight why this matters. 18 February 2025